… as an advanced version of non-integrated gene-replacement … and promising targets of
atherosclerosis gene therapy. The … of common delivery vectors or methods for gene therapy were …

… , effectively advanced to deliver the desired treatment from … The birth of gene therapy for
cardiovascular disorders in the … shows 3 current gene therapy approaches targeted to cardiac …

… the current status and future developments in this field. … targets, improved vectors and
delivery methods in the last decade has made gene therapy a realistic option for treating heart …

… cardiovascular diseases with genetic etiologies, gene therapy can also be utilized in cases
of cardiovascular … There are many methods to deliver gene therapy and gene correction …

… vector is increasingly being used for ex vivo gene delivery. … gene therapy for the treatment
of non-cardiac diseases has … targeted delivery to the heart might be required to advance …

… the gene therapy drugs and their current application progress… reporter gene assay confirmed
that miR-218 targeted the … miRNA can treat cardiovascular diseases by regulating heart …

… In this review, we highlight gene therapy developments, in particular, AAV and LV HSPC-…
Muscle Directed Delivery Gene therapy targeting muscle could directly correct the affected …

… gene therapy in overcoming some of these limitations, it still faces with complexities such as
substantial barriers to delivery of the vector, targeting … for immune dysfunction, heart disease, …

… therapeutic targets suggested to be causal for CVD; (ii) there is a substantial recent progress
in delivery, … for non-cardiac monogenic diseases and LDL receptor gene therapy is currently …

… Cardiac gene therapy using an AAV as a vector is becoming a new platform for treating and
even curing currently intractable heart disease. … platform for targeted, intelligent delivery and …